Thor M, Shepherd AF, Apte A, Offin M, et al. Pre-Treatment Immune-Related Markers Predict Disease Outcomes in Non-Small Cell Lung Cancer Patients Treated With Chemoradiation and Durvalumab. Int J Radiat Oncol Biol Phys 2021;111.
PMID: 34700410